Home
Acuitas Therapeutics

Acuitas Therapeutics Market Share Analysis for August 2026

Acuitas is the global leader in the development of lipid nanoparticle delivery systems. Learn more about the real world applications of our unmatched LNP platform.

Health > Biotechnology and Pharmaceuticals

Domainacuitastx.com

Year Founded2009

Employees51 - 200

Annual Revenue$10M - $15M

Acuitas Therapeutics

Acuitas Therapeutics (including company regionals)

acuitastx.com

See more website traffic and engagement information

Acuitas Therapeutics Revenue up to August 2026 is 10M - 15M

revenue generated by Acuitas Therapeutics top domains

Acuitas Therapeutics top domains revenue over 3 years

Revenue for Acuitas Therapeutics top domains

acuitastx.com10M - 15M

See more with Sales Intelligence

Total visits to Acuitas Therapeutics's top domains

Understand Acuitas Therapeutics market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

acuitastx.com8.3K

See more with Sales Intelligence

Avg. visit duration in Acuitas Therapeutics's top domains

Analyze Acuitas Therapeutics engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

acuitastx.com00:00:37

See more with Sales Intelligence

Avg. pageviews on Acuitas Therapeutics's top domains

See how Acuitas Therapeutics keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

acuitastx.com1.87

See more with Sales Intelligence

Acuitas Therapeutics top competitors by domain

Looks like there’s not enough data here

No Data to Display

Top technologies used by Acuitas Therapeutics

These are the website technologies, by industry, used by Acuitas Therapeutics top domains

Widget (9)

Twemoji

Email Services (3)

Microsoft Exchange Online

Advertising (2)

DoubleClick

Audio Video Media (2)

YouTube

More Technologies

8

See all

News & Signals from Acuitas Therapeutics

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsCREATE Medicines, Inc. partners with Acuitas Therapeutics, Inc..CREATE's growing global footprint now includes three targeted-delivery partnerships across three continents: WestGene in China, a research collaboration with Monash University in Australia, and a strategic collaboration with Acuitas Therapeutics in Canada.

NewsAcuitas Therapeutics, Inc. attended event 2026 ASGCT Annual Meeting on May 20th '26.Acuitas Therapeutics highlights In Vivo CAR T Cell engineering and ionizable lipid quality attributes at the 2026 ASGCT Annual Meeting.

NewsCompany partnered with Acuitas on Apr 20th '26.LONDON, UK / ACCESS Newswire / April 20, 2026 / Genflow Biosciences Plc (LSE:GENF)(OTCQB:GENFF) ("Genflow" or the "Company"), a European biotechnology company focused on the development of gene therapies for age-related diseases, today announces that it has entered into a strategic technology collaboration with Acuitas Therapeutics ("Acuitas"), a globally recognised leader in lipid nanoparticle ("LNP") delivery systems whose technology has underpinned some of the most commercially successful mRNA therapeutic programmes brought to market to date.